Author

P. Ortiz-Romero

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Animal Behavior & Cognition· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:behavioral assay· 2 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

V. Campuzano· 2 shared A. Llorente-Ovejero· 1 shared A. Mas-Stachurska· 1 shared A. Navarro-Romero· 1 shared A. Ozaita· 1 shared A. Pastor· 1 shared B. Benito· 1 shared E. Eyras· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersAnimal Behavior & Cognition

V. Campuzano

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Animal Behavior & CognitionbioRxivPreprintAug 16, 2021

Cannabinoid signaling modulation through JZL184 restores key phenotypes of a mouse model for Williams-Beuren syndrome

A. Navarro-Romero, L. Galera-Lopez, P. Ortiz-Romero…·A. Ozaita

This study shows that JZL184 treatment improves social, cognitive, and cardiac phenotypes in a mouse model of Williams-Beuren syndrome by modulating the endocannabinoid system.

DOI 10.1101/2021.08.16.456474

mousebehavioral assay

𝕏 PostBluesky

Animal Behavior & CognitionFrontiers in PharmacologyPeer-reviewedAug 3, 2021

Verapamil/Curcumin treatment attenuates the behavioral alterations observed in Williams Syndrome mice by regulation of MAPK pathway and Microglia overexpression

P. Ortiz-Romero, G. Egea, L. A. Perez-Jurado, V. Campuzano

This study shows that curcumin and verapamil combination treatment improves behavioral deficits in Williams Syndrome mice by regulating MAPK pathway and reducing microglia activation.

DOI 10.3389/fphar.2021.670785

mousebehavioral assay

𝕏 PostBluesky